A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/519 (2006.01) A61K 31/417 (2006.01) A61K 31/473 (2006.01) A61K 31/475 (2006.01) A61K 31/517 (2006.01) A61K 31/5578 (2006.01) A61K 31/568 (2006.01) A61K 31/5685 (2006.01) A61K 31/724 (2006.01) A61K 45/06 (2006.01) A61K 47/40 (2006.01) A61P 15/10 (2006.01)
Patent
CA 2367605
The treatment of sexual dysfunction in human patients by an oral therapy regimen of administration of apomorphine and sildenafil is disclosed. This treatment optimizes the efficacy of each drug and substantially minimizes the undesirable side effects associated individually therewith. Apomorphine and sildenafil can be co-administered with a combination dosage unit or administered sequentially in separate dosage units, substantially prior to sexual activity. Other erectogenic agents can be administered along with apomorphine and sildenafil.
L'invention concerne le traitement des troubles sexuels chez l'homme par l'administration per os d'apomorphine et de sildénafil. Le traitement optimise l'efficacité de chaque médicament et minimise sensiblement les effets secondaires indésirables associés à chacun d'eux séparément. L'apomorphine et le sildénafil peuvent être co-administrés sous forme d'unité posologique combinée ou bien être administrés séquentiellement sous forme d'unités posologiques séparées, sensiblement avant l'activité sexuelle. D'autres agents érectogènes peuvent être administrés en même temps que l'apomorphine et le sildénafil.
Cassan Maclean
Pentech Pharmaceuticals,inc
LandOfFree
Apomorphine and sildenafil composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apomorphine and sildenafil composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apomorphine and sildenafil composition will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1666532